Evidence mapPaperPMID 40778272Full record

ArticleFrontiers in endocrinology2025

Associations of triglyceride-glucose index and metabolic score for insulin resistance with various hypertension phenotypes in children and adolescents: results from the 2017 China nutrition and health surveillance.

Haiyuan Zhu, Lianlong Yu, Qiqi Wu, Runquan Zhang, Zebang Zhang, Yumei Feng, Tao Liu, Dan Liu, Jiewen Peng, Xiongfei Chen and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haiyuan Zhu *Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Lianlong Yu *Health Management Institute, Shandong Center for Disease Control and Prevention, Jinan, China.
Qiqi WuDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Runquan ZhangDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Zebang ZhangDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Yumei FengDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Tao LiuDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Dan LiuDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, China.
Jiewen PengGuangdong Provincial Institute of Public Health, Guangdong Center for Disease Control and Prevention, Guangzhou, China.
Xiongfei ChenDepartment of Primary Public Health, Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
Xiaomei DongDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of hypertension in children is rising globally, with early-onset high blood pressure linked to future cardiovascular risk. Identifying early risk markers beyond obesity and high salt intake is necessary. Although cost-effective indicators of insulin resistance (IR), such as TyG and METS-IR, have been associated with new-onset hypertension in adults, their links with pediatric hypertension, particularly specific phenotypes of hypertension remain unclear. Methods: 12,087 individuals aged 7-17 years from the 2017 China National Nutrition and Health Surveillance of Children and Lactating Women were included. Hypertension was defined as systolic blood pressure (SBP) and/or diastolic blood pressure (DBP) ≥95th percentile for sex, age, and height. Isolated systolic hypertension (ISH), defined as SBP ≥95th and DBP <95th percentile. Isolated diastolic hypertension (IDH), defined as DBP ≥95th and SBP <95th percentile. Systolic-diastolic hypertension (SDH), defined as both SBP and DBP ≥95th percentile. The associations of TyG and METS-IR with hypertension phenotypes were investigated using multivariable logistic regression and restricted cubic spline regression. Results: TyG and METS-IR were positively associated with hypertension and all its phenotypes after multivariable adjustment. Treated as continuous variables, each 1-unit rise in TyG corresponds to 44%, 47%, and 61% higher chance of ISH, IDH, and SDH, respectively (odds ratio [OR]: 1.44, 95% confidence interval [CI]: 1.31-1.59; OR: 1.47, 95%CI: 1.21-1.79; OR: 1.61, 95%CI: 1.35-1.91); each 1-unit rise in METS-IR corresponds to 10%, 6%, and 12% higher chance of ISH, IDH, and SDH, respectively (OR: 1.10, 95%CI: 1.09-1.12; OR: 1.06, 95%CI: 1.03-1.08; OR: 1.12, 95%CI: 1.10-1.14). Consistent positive associations were observed across different subgroups for ISH and SDH, whereas this association for IDH was not statistically significant in several subgroups (e.g., age ≥12 years, sufficient sleep, daily exercise). TyG and METS-IR exhibited linear dose-response relationships with all hypertension phenotypes (p-nonlinear >0.10). Conclusion: TyG and METS-IR show strong relationships with three kinds of hypertension phenotypes. They are promising markers that may contribute to the primary prevention of hypertension in pediatric populations.

Indexed as

Blood GlucoseHypertensionInsulin ResistanceTriglyceridesAdolescentBiomarkersBlood PressureChildChinaCross-Sectional StudiesFemaleHumansMaleMetabolic SyndromeNutrition SurveysPhenotypeBiomarkersBlood GlucoseTriglyceridesadolescentsblood pressurechildrenhypertensioninsulin resistanceMETS-IRTyG

Identifiers

PMID40778272
PMCPMC12328147

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.